Page last updated: 2024-08-26

alpha-glutamyltryptophan and Adenocarcinoma

alpha-glutamyltryptophan has been researched along with Adenocarcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bouchillon, K; Brown, MA; Carter, CM; Daliani, DD; Do, KA; Kim, J; Logothetis, CJ; Mao, S; Perez, CA; Thall, PF; Wang, X	1

Trials

1 trial(s) available for alpha-glutamyltryptophan and Adenocarcinoma

Article	Year
Employing the treatment-free interval of intermittent androgen ablation to screen candidate prostate cancer therapies. The Prostate, 2007, Nov-01, Volume: 67, Issue:15 Topics: Adenocarcinoma; Adjuvants, Immunologic; Administration, Intranasal; Androgen Antagonists; Angiogenesis Inhibitors; Antineoplastic Agents, Hormonal; Combined Modality Therapy; Dipeptides; Disease Progression; Double-Blind Method; Drug Administration Schedule; Humans; Male; Neoplasm Recurrence, Local; Prostatic Neoplasms; Treatment Outcome	2007

Article

Year

Employing the treatment-free interval of intermittent androgen ablation to screen candidate prostate cancer therapies.

The Prostate, 2007, Nov-01, Volume: 67, Issue:15

Topics: Adenocarcinoma; Adjuvants, Immunologic; Administration, Intranasal; Androgen Antagonists; Angiogenesis Inhibitors; Antineoplastic Agents, Hormonal; Combined Modality Therapy; Dipeptides; Disease Progression; Double-Blind Method; Drug Administration Schedule; Humans; Male; Neoplasm Recurrence, Local; Prostatic Neoplasms; Treatment Outcome

2007